In this episode, Professor Mal Hopwood and Professor Colleen Loo discuss the introduction of esketamine to the Pharmaceutical Benefits Scheme (PBS) in Australia. They explore the mechanism of action of esketamine, its clinical trials, practical applications, treatment protocols, costs, safety monitoring, and the importance of informed consent. The conversation emphasises the need for proper patient expectations and long-term treatment considerations in managing treatment-resistant depression....